MDxHealth SA - Ordinary Shares (MDXH)

MDxHealth (MDXH) Q1 2026 Earnings Transcript

MDxHealth (NASDAQ:MDXH) reported first-quarter 2026 revenue of $27.4 million while announcing a strategic exit from its Resolve UTI testing business and the planned closure of its Plano, Texas, laboratory facility, a move executives said will sharpen the company’s focus on prostate cancer diagnostic

MDxHealth (MDXH) Q4 2025 Earnings Call Transcript

MDxHealth (MDXH) Q3 2025 Earnings Call Transcript

MDxHealth reported mixed Q3 2025 results with 18% revenue growth and a key milestone of positive adjusted EBITDA, despite missing top-line estimates.

MDxHealth (MDXH) stock shows strong technical uptrend and fundamental growth momentum, meeting criteria for high-growth investors.

After months of work, we’re proud to release the Master Swing Trading Course - a 175-page deep dive designed from your feedback and our three decades of market experience.

MDXH stock results show that MDxHealth missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

MDXH stock results show that MDxHealth missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.